Farther Finance Advisors »

Corvus Pharmaceuticals shares owned by Farther Finance Advisors

Quarter-by-quarter ownership of Corvus Pharmaceuticals (CRVS) shares owned by Farther Finance Advisors from 13F filings

Historical chart of Farther Finance Advisors investment in Corvus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Corvus Pharmaceuticals held by Farther Finance Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corvus Pharmaceuticals by Farther Finance Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.5k 323 7.70

More positions owned by Farther Finance Advisors

Ishares Core S&p 500 Etf Etf (IVV)
Apple Stock (AAPL)
Vanguard S&p 500 Etf Etf (VOO)
Nvidia Corporation Stock (NVDA)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Dimensional International Value Etf Etf (DFIV)
Microsoft Corp Stock (MSFT)
Schwab U.s. Large-cap Etf Etf (SCHX)
Ishares 0-3 Month Treasury Bond Etf Etf (SGOV)
Amazon Stock (AMZN)
Invesco Qqq Trust Series I Etf (QQQ)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Vanguard Short-term Corporate Bond Etf Etf (VCSH)
Vanguard Value Etf Etf (VTV)

View all positions for Farther Finance Advisors

Top funds holding Corvus Pharmaceuticals

OrbiMed Advisors
BlackRock
Vanguard Group
Adams Street Partners
Point72 Asset Management
State Street Corporation
MPM Oncology Impact Management
Vivo Capital
Geode Capital Management
Perceptive Advisors
Foresite Capital Management VI
DCF Advisers
Susquehanna International
Goldman Sachs Group
Logos Global Management

View all funds holding Corvus Pharmaceuticals